Brain imaging studies of appetite in the context of obesity and the menstrual cycle

Human Reproduction Update

Volumn 16, Issue 3, 2009, Pages 276-292

  van Vugt, Dean A ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

Appetite; Functional magnetic resonance imaging; Homeostatic; Menstrual cycle; Obesity

Indexed keywords

ADIPONECTIN; AMYLIN; CHOLECYSTOKININ; ESTROGEN RECEPTOR; GHRELIN; GLUCAGON LIKE PEPTIDE 1; LEPTIN; OXYNTOMODULIN; PEPTIDE YY; STEROID;

ANOREXIA; APPETITE; ASSOCIATION; BULIMIA; CALORIC INTAKE; DIET; ENERGY EXPENDITURE; FOOD; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HORMONE ACTION; HUMAN; INGESTION; MEDLINE; MENSTRUAL CYCLE; NERVE CELL NETWORK; NEUROENDOCRINE SYSTEM; NEUROIMAGING; NONHUMAN; OBESITY; OVARY; PRIORITY JOURNAL; PUBLICATION; REPRODUCTION; REVIEW; ANIMAL; ANOREXIA NERVOSA; BRAIN; FEMALE; FEMALE INFERTILITY; FOOD INTAKE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; ANOREXIA NERVOSA; APPETITE REGULATION; BRAIN; BULIMIA NERVOSA; FEMALE; HUMANS; INFERTILITY, FEMALE; MAGNETIC RESONANCE IMAGING; MENSTRUAL CYCLE; OBESITY;

EID: 77954507360     PISSN: 13554786     EISSN: 14602369     Source Type: Journal    
DOI: 10.1093/humupd/dmp051     Document Type: Review

References (222)

1. Abizaid A, Gao Q, Horvath TL. Thoughts for Food: Brain mechanisms and peripheral energy balance. Neuron 2006;51:691-702.
2. Ahima RS, Prabakaran D, Mantzoros C, Qu D, Lowell B, Maratos-Flier E, Flier JS. Role of leptin in the neuroendocrine response to fasting. Nature 1996;382:250-252.
3. Allison DB, Fontaine KR, Manson JE, Stevens J, VanItallie TB. Annual deaths attributable to obesity in the United States. J Am Med Assoc 1999;282:1530-1538.
4. Arthurs OJ, Boniface S. How well do we understand the neural origins of the fMRI BOLD signal? Trends Neurosci 2002;25:27-31.
5. Asarian L, Geary N. Cyclic estradiol treatment phasically potentiates endogenous cholecystokinin's satiating action in ovariectomized rats. Peptides 1999;20:445-450.
6. Asarian L, Geary N. Modulation of appetite by gonadal steroid hormones. Philos Trans R Soc B: Biol Sci 2006;361:1251-1263.
7. Asimakopoulos B, Milousis A, Gioka T, Kabouromiti G, Gianisslis G, Troussa A, Simopoulou M, Katergari S, Tripsianis G, Nikolettos N. Serum pattern of circulating adipokines throughout the physiological menstrual cycle. Endocr J 2009;56:425-433.
8. Baicy K, London ED, Monterosso J, Wong ML, Delibasi T, Sharma A, Licinio J. From the Cover: Leptin replacement alters brain response to food cues in genetically leptin-deficient adults. PNAS 2007; 104:18276-18279.
9. Balen AH, Dresner M, Scott EM, Drife JO. Should obese women with polycystic ovary syndrome receive treatment for infertility? Br Med J 2006;332:434-435.
10. Ballantyne GH. Peptide YY(1-36) and peptide YY(3-36): Part II. Changes after gastrointestinal surgery and bariatric surgery. Obes Surg 2006; 16:795-803.
11. Barr SI, Janelle KC, Prior JC. Energy intakes are higher during the luteal phase of ovulatory menstrual cycles. Am J Clin Nutr 1995;61:39-43.
12. Baskin DG, Hahn TM, Schwartz MW. Leptin sensitive neurons in the hypothalamus. Horm Metab Res 1999;31:345-350.
13. Batterham RL, Cowley MA, Small CJ, Herzog H, Cohen MA, Dakin CL, Wren AM, Brynes AE, Low MJ, Ghatei MA et al. Gut hormone PYY(3-36) physiologically inhibits food intake. Nature 2002;418:650-654.
14. Batterham RL, ffytche DH, Rosenthal JM, Zelaya FO, Barker GJ, Withers DJ, Williams SCR. PYY modulation of cortical and hypothalamic brain areas predicts feeding behaviour in humans. Nature 2007;450:106-109.
15. Beaver JD, Lawrence AD, van Ditzhuijzen J, Davis MH, Woods A, Calder AJ. Individual differences in reward drive predict neural responses to images of food. J Neurosci 2006;26:5160-5166.
16. Berridge KC. Food reward: brain substrates of wanting and liking. Neurosci Biobehav Rev 1996;20:1-25.
17. Berthoud HR. Multiple neural systems controlling food intake and body weight. Neurosci Biobehav Rev 2002;26:393-428.
18. Blaustein JD, Wade GN. Ovarian influences on the meal patterns of female rats. Physiol Behav 1976;17:201-208.
19. Blevins JE, Stanley BG, Reidelberger RD. Brain regions where cholecystokinin suppresses feeding in rats. Brain Res 2000;860:1-10.
20. Boutrel B, de Lecea L. Addiction and arousal: the hypocretin connection. Physiol Behav 2008;93:947-951.
21. Bowen DJ, Grunberg NE. Variations in food preference and consumption across the menstrual cycle. Physiol Behav 1990;47:287-291.
22. Broberger C, Landry M, Wong H, Walsh JN, Hokfelt T. Subtypes Y1 and Y2 of the neuropeptide Y receptor are respectively expressed in pro-opiomelanocortin-and neuropeptide-Y-containing neurons of the rat hypothalamic arcuate nucleus. Neuroendocrinology 1997; 66:393-408.
23. Buffenstein R, Poppitt SD, McDevitt RM, Prentice AM. Food intake and the menstrual cycle: a retrospective analysis, with implications for appetite research. Physiol Behav 1995;58:1067-1077.
24. Buse JB, Henry RR, Han J, Kim DD, Fineman MS, Baron AD, and for the Exenatide-113 study group. Effects of exenatide (exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients with type 2 diabetes. Diabetes Care 2004;27:2628-2635.
25. Cabanac M. Physiological role of pleasure. Science 1971;173:1103-1107.
26. Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 1995;269:546-549.
27. Cedergren MI. Maternal morbid obesity and the risk of adverse pregnancy outcome. Obstet Gynecol 2004;103:219-224.
28. Cella F, Giordano G, Cordera R. Serum leptin concentrations during the menstrual cycle in normal-weight women: effects of an oral triphasic estrogen-progestin medication. Eur J Endocrinol 2000;142:174-178.
29. Challis BG, Pinnock SB, Coll AP, Carter RN, Dickson SL, O'Rahilly S. Acute effects of PYY3-36 on food intake and hypothalamic neuropeptide expression in the mouse. Biochem Biophys Res Commun 2003;311:915-919.
30. Chelikani PK, Haver AC, Reidelberger RD. Intravenous infusion of peptide yy(3-36) potently inhibits food intake in rats. Endocrinology 2005; 146:879-888.
31. Childress AR, Mozley PD, McElgin W, Fitzgerald J, Reivich M, O'Brien CP. Limbic activation during cue-induced cocaine craving. Am J Psychiatry 1999;156:11-18.
32. Christophe J. Is there appetite after glp-1 and pacap? Ann N Y Acad Sci 1998;865:323-335.
33. Clark AM, Thornley B, Tomlinson L, Galletley C, Norman RJ.Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment. Hum Reprod 1998;13:1502-1505.
34. Clegg DJ, Brown LM, Woods SC, Benoit SC. Gonadal hormones determine sensitivity to central leptin and insulin. Diabetes 2006; 55:978-987.
35. Cockerill IM,Wormington JA, Nevill AM. Menstrual-cycle effects on mood and perceptual-motor performance. J Psychosom Res 1994;38:763-771.
36. Cornier MA, Von Kaenel SS, Bessesen DH, Tregellas JR. Effects of overfeeding on the neuronal response to visual food cues. Am J Clin Nutr 2007;86:965-971.
37. Cowley MA, Smart JL, Rubinstein M, Cerdan MG, Diano S, Horvath TL, Cone RD, Low MJ. Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature 2001; 411:480-484.
38. Cox JE, Randich A. Enhancement of feeding suppression by PYY(3-36) in rats with area postrema ablations. Peptides 2004;25:985-989.
39. Creutz LM, Kritzer MF. Estrogen receptor-beta immunoreactivity in the midbrain of adult rats: regional, subregional, and cellular localization in the A10, A9, and A8 dopamine cell groups. J Comp Neurol 2002; 446:288-300.
40. Critchley HD, Mathias CJ, Dolan RJ. Fear conditioning in humans: the influence of awareness and autonomic arousal on functional neuroanatomy. Neuron 2002;33:653-663.
41. Cross GB, Marley J, Miles H, Willson K. Changes in nutrient intake during the menstrual cycle of overweight women with premenstrual syndrome. Br J Nutr 2001;85:475-482.
42. Cummings DE, Clement K, Purnell JQ, Vaisse C, Foster KE, Frayo RS, Schwartz MW, Basdevant A, Weigle DS. Elevated plasma ghrelin levels in Prader Willi syndrome. Nat Med 2002a;8:643-644.
43. Cummings DE, Weigle DS, Frayo RS, Breen PA, Ma MK, Dellinger EP, Purnell JQ. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med 2002b;346:1623-1630.
44. Czaja JA. Ovarian influences on primate food intake: assessment of progesterone actions. Physiol Behav 1978;21:923-928.
45. Dafopoulos K, Sourlas D, Kallitsaris A, Pournaras S, Messinis IE. Blood ghrelin, resistin, and adiponectin concentrations during the normal menstrual cycle. Fertil Steril 2009;92:1389-1394.
46. Dalvit SP. The effect of the menstrual cycle on patterns of food intake. Am J Clin Nutr 1981;34:1811-1815.
47. de Lecea L, Kilduff TS, Peyron C, Gao XB, Foye PE, Danielson PE, Fukuhara C, Battenberg ELF, Gautvik VT, Bartlett FS et al. The hypocretins: hypothalamus-specific peptides with neuroexcitatory G Çëactivity. Proc Natl Acad Sci USA 1998;95:322-327.
48. DeFronzo RA, Ratner RE, Han J, Kim DD, Fineman MS, Baron AD. Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes. Diabetes Care 2005; 28:1092-1100.
49. Degen L, Oesch S, Casanova M, Graf S, Ketterer S, Drewe J, Beglinger C. Effect of peptide yy3-36 on food intake in humans. Gastroenterology 2005;129:1430-1436.
50. DelParigi A, Chen K, Gautier JF, Salbe AD, Pratley RE, Ravussin E, Reiman EM, Tataranni PA. Sex differences in the human brain's response to hunger and satiation. Am J Clin Nutr 2002;75:1017-1022.
51. Diano S, Kalra SP, Sakamoto H, Horvath TL. Leptin receptors in estrogen receptor-containing neurons of the female rat hypothalamus. Brain Res 1998;812:256-259.
52. Diano S, Farr SA, Benoit SC, McNay EC, da Silva I, Horvath B, Gaskin FS, Nonaka N, Jaeger LB, Banks WA et al. Ghrelin controls hippocampal spine synapse density and memory performance. Nat Neurosci 2006; 9:381-388.
53. Diez JJ, Iglesias P. The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur J Endocrinol 2003; 148:293-300.
54. Dumont Y, Jacques D, Bouchard P, Quirion R. Species differences in the expression and distribution of the neuropeptide Y Y1, Y2, Y4, and Y5 receptors in rodents, guinea pig, and primates brains. J Comp Neurol 1998;402:372-384.
55. Dye L, Blundell JE. Menstrual cycle and appetite control: implications for weight regulation. Hum Reprod 1997;12:1142-1151.
56. Eckel LA, Houpt TA, Geary N. Estradiol treatment increases CCK-induced c-Fos expression in the brains of ovariectomized rats. Am J Physiol Regul Integr Comp Physiol 2002;283:R1378-R1385.
57. Edwards CM, Stanley SA, Davis R, Brynes AE, Frost GS, Seal LJ, Ghatei MA, Bloom SR. Exendin-4 reduces fasting and postprandial glucose and decreases energy intake in healthy volunteers. Am J Physiol Endocrinol Metab 2001;281:E155-E161.
58. Elias CF, Lee C, Kelly J, Aschkenasi C, Ahima RS, Couceyro PR, Kuhar MJ, Saper CB, Elmquist JK. Leptin activates hypothalamic cart neurons projecting to the spinal cord. Neuron 1998;21:1375-1385.
59. Elias CF, Aschkenasi C, Lee C, Kelly J, Ahima RS, Bjorbaek C, Flier JS, Saper CB, Elmquist JK. Leptin differentially regulates npy and pomc neurons projecting to the lateral hypothalamic area. Neuron 1999; 23:775-786.
60. Elmquist JK, Ahima RS, Elias CF, Flier JS, Saper CB. Leptin activates distinct projections from the dorsomedial and ventromedial hypothalamic nuclei. Proc Natl Acad Sci USA 1998;95:741-746.
61. Farooqi IS, Jebb SA, Langmack G, Lawrence E, Cheetham CH, Prentice AM, Hughes IA, McCamish MA, O'Rahilly S. Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N Engl J Med 1999;341:879-884.
62. Farooqi IS, Matarese G, Lord GM, Keogh JM, Lawrence E, Agwu C, Sanna V, Jebb SA, Perna F, Fontana S et al. Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J Clin Invest 2002; 110:1093-1103.
63. Farooqi IS, Bullmore E, Keogh J, Gillard J, O'Rahilly S, Fletcher PC. Leptin regulates striatal regions and human eating behavior. Science 2007; 317:1355.
64. Fedorcsak P, Dale PO, Storeng R, Ertzeid G, Bjercke S, Oldereid N, Omland AK, Abyholm T, Tanbo T. Impact of overweight and underweight on assisted reproduction treatment. Hum Reprod 2004; 19:2523-2528.
65. Figlewicz DP, Evans SB, Murphy J, Hoen M, Baskin DG. Expression of receptors for insulin and leptin in the ventral tegmental area/substantia nigra (VTA/SN) of the rat. Brain Res 2003;964:107-115.
66. Finkelstein EA, Fiebelkorn IC, Wang G. State-level estimates of annual medical expenditures attributable to obesity. Obesity Res 2004; 12:18-24.
67. Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence and trends in obesity among us adults, 1999-2000. J Am Med Assoc 2002; 288:1723-1727.
68. Fogteloo J, Meinders E, Fr4lich M, McCamish M, Pijl H. The decline in plasma leptin in response to calorie restriction predicts the effects of adjunctive leptin treatment on body weight in humans. Eur J Intern Med 2003;14:415-418.
69. Fong TM. Advances in anti-obesity therapeutics. Expert Opin Investig Drugs 2005;14:243-250.
70. Gambacciani M, Ciaponi M, Cappagli B, Piaggesi L, De Simone L, Orlandi R, Genazzani AR. Body weight, body fat distribution, and hormonal replacement therapy in early postmenopausal women. J Clin Endocrinol Metab 1997;82:414-417.
71. Gantz I, Erondu N, Mallick M, Musser B, Krishna R, Tanaka WK, Snyder K, Stevens C, Stroh MA, Zhu H et al. Efficacy and safety of intranasal peptide yy3-36 for weight reduction in obese adults. J Clin Endocrinol Metab 2007;92:1754-1757.
72. Gautier JF, Chen K, Salbe AD, Bandy D, Pratley RE, Heiman M, Ravussin E, Reiman EM, Tataranni PA. Differential brain responses to satiation in obese and lean men. Diabetes 2000;49:838-846.
73. Gautier JF, Del PA, Chen K, Salbe AD, Bandy D, Pratley RE, Ravussin E, Reiman EM, Tataranni PA. Effect of satiation on brain activity in obese and lean women. Obes Res 2001;9:676-684.
74. Geary N, Asarian L, Korach KS, Pfaff DW, Ogawa S. Deficits in E2-dependent control of feeding, weight gain, and cholecystokinin satiation in er-{alpha} null mice. Endocrinology 2001;142:4751-4757.
75. Geisthovel F, Jochmann N, Widjaja A, Horn R, Brabant G. Serum pattern of circulating free leptin, bound leptin, and soluble leptin receptor in the physiological menstrual cycle. Fertil Steril 2004;81:398-402.
76. George MS, Anton RF, Bloomer C, Teneback C, Drobes DJ, Lorberbaum JP, Nahas Z, Vincent DJ. Activation of prefrontal cortex and anterior thalamus in alcoholic subjects on exposure to alcohol-specific cues. Arch Gen Psychiatry 2001;58:345-352.
77. Gibbs J, Young RC, Smith GP. Cholecystokinin decreases food intake in rats. J Comp Physiol Psychol 1973;84:488-495.
78. Goldstein BJ, Scalia R. Adiponectin: A novel adipokine linking adipocytes and vascular function. J Clin Endocrinol Metab 2004;89:2563-2568.
79. Gong EJ, Garrel D, Calloway DH. Menstrual cycle and voluntary food intake. Am J Clin Nutr 1989;49:252-258.
80. Goodall EM, Whittle M, Cookson J, Cowen PJ, Silverstone T. Menstrual cycle effects on the action of buspirone on food intake in healthy female volunteers. J Psychopharmacol 1995;9:307-312.
81. Gottfried JA, O'Doherty J, Dolan RJ. Encoding predictive reward value in human amygdala and orbitofrontal cortex. Science 2003; 301:1104-1107.
82. Grandt D, Schimiczek M, Beglinger C, Layer P, Goebell H, Eysselein VE, Reeve J. Two molecular forms of Peptide YY (PYY) are abundant in human blood: characterization of a radioimmunoassay recognizing PYY 1-36 and PYY 3-36. Regul Pept 1994;51:151-159.
83. Grusser SM, Wrase J, Klein S, Hermann D, Smolka MN, Ruf M, Weber-Fahr W, Flor H, Mann K, Braus DF et al. Cue-induced activation of the striatum and medial prefrontal cortex is associated with subsequent relapse in abstinent alcoholics. Psychopharmacology (Berl) 2004;175:296-302.
84. Gundlah C, Kohama SG, Mirkes SJ, Garyfallou VT, Urbanski HF, Bethea CL. Distribution of estrogen receptor beta (ER[beta]) mRNA in hypothalamus, midbrain and temporal lobe of spayed macaque: continued expression with hormone replacement. Mol Brain Res 2000; 76:191-204.
85. Gustafson EL, Smith KE, Durkin MM, Walker MW, Gerald C, Weinshank R, Branchek TA. Distribution of the neuropeptide Y Y2 receptor mRNA in rat central nervous system. Mol Brain Res 1997; 46:223-235.
86. Gutzwiller JP, Goke B, Drewe J, Hildebrand P, Ketterer S, Handschin D, Winterhalder R, Conen D, Beglinger C. Glucagon-like peptide-1: a potent regulator of food intake in humans. Gut 1999;44:81-86.
87. Haarbo J, Marslew U, Gotfredsen A, Christiansen C. Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause. Metabolism 1991;40:1323-1326.
88. Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK, Friedman JM. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995; 269:543-546.
89. Halatchev IG, Ellacott KLJ, FanW, Cone RD. Peptide YY3-36 inhibits food intake in mice through a melanocortin-4 receptor-independent mechanism. Endocrinology 2004;145:2585-2590.
90. Hardie L, Trayhurn P, Abramovich D, Fowler P. Circulating leptin in women: a longitudinal study in the menstrual cycle and during pregnancy. Clin Endocrinol (Oxf) 1997;47:101-106.
91. Harrold JA, Williams G. The cannabinoid system: a role in both the homeostatic and hedonic control of eating? Br J Nutr 2003;90:729-734.
92. Henry BA, Clarke IJ. Adipose tissue hormones and the regulation of food intake. J Neuroendocrinol 2008;20:842-849.
93. Heymsfield SB, Greenberg AS, Fujioka K, Dixon RM, Kushner R, Hunt T, Lubina JA, Patane J, Self B, Hunt P et al. Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial. J Am Med Assoc 1999;282:1568-1575.
94. Hinton EC, Parkinson JA, Holland AJ, Arana FS, Roberts C, Owen AM. Neural contributions to the motivational control of appetite in humans. Eur J Neurosci 2004;20:1411-1418.
95. Holland PC, Gallagher M. Amygdala-frontal interactions and reward expectancy. Curr Opin Neurobiol 2004;14:148-155.
96. Holsen LM, Zarcone JR, Brooks WM, Butler MG, Thompson TI, Ahluwalia JS, Nollen NL, Savage CR. Neural mechanisms underlying hyperphagia in Prader-Willi Syndrome. Obesity Res 2006; 14:1028-1037.
97. Hommel JD, Trinko R, Sears RM, Georgescu D, Liu ZW, Gao XB, Thurmon JJ, Marinelli M, DiLeone RJ. Leptin receptor signaling in midbrain dopamine neurons regulates feeding. Neuron 2006;51:801-810.
98. Hudson JI, Hiripi E, Pope J, Kessler RC. The prevalence and correlates of eating disorders in the national comorbidity survey replication. Biol Psychiatry 2007;61:348-358.
99. Hukshorn CJ, van Dielen FM, Buurman WA, Westerterp-Plantenga MS, Campfield LA, Saris WH. The effect of pegylated recombinant human eptin (PEG-OB) on weight loss and inflammatory status in obese subjects. Int J Obes Relat Metab Disord 2002;26:504-509.
100. Jankowiak R, Stern JJ. Food intake and body weight modifications following medial hypothalamic hormone implants in female rats. Physiol Behav 1974;12:875-879.
101. Jayasena CN, Bloom SR. Role of gut hormones in obesity. Endocrinol Metab Clin North Am 2008;37:769-787.
102. Kaga T, Fujimiya M, Inui A. Emerging functions of neuropeptide Y Y2 receptors in the brain. Peptides 2001;22:501-506.
103. Karhunen LJ, Lappalainen RI, Vanninen EJ, Kuikka JT, Uusitupa MI. Regional cerebral blood flow during food exposure in obese and normal-weight women. Brain 1997;120:1675-1684.
104. Kelley AE. Ventral striatal control of appetitive motivation: role in ingestive behavior and reward-related learning. Neurosci Biobehav Rev 2004; 27:765-776.
105. Kelner K, Helmuth L. Obesity-what is to be done? Science 2003;299:845.
106. Kemnitz JW, Eisele SG, Lindsay KA, Engle MJ, Perelman RH, Farrell PM. Changes in food intake during menstrual cycles and pregnancy of normal and diabetic rhesus monkeys. Diabetologia 1984;26:60-64.
107. Kemnitz JW, Gibber JR, Lindsay KA, Eisele SG. Effects of ovarian hormones on eating behaviors, body weight, and glucoregulation in rhesus monkeys. Horm Behav. 1989;23:235-250.
108. Killgore WD, Yurgelun-Todd DA. Affect modulates appetite-related brain activity to images of food. Int J Eat Disord 2006;39:357-363.
109. Killgore WDS, Young AD, Femia LA, Bogorodzki P, Rogowska J, Yurgelun-Todd DA. Cortical and limbic activation during viewing of high-versus low-calorie foods. NeuroImage 2003;19:1381-1394.
110. Kim G, Van Vugt DA. Influence of menstrual cycle phase on subjective responses to visual food cues. Annual Meeting of the Society for Neuroscience 2008; Abstract 583.3.
111. Koegler FH, Enriori PJ, Billes SK, Takahashi DL, Martin MS, Clark RL, Evans AE, Grove KL, Cameron JL, Cowley MA. Peptide YY(3-36) inhibits morning, but not evening, food intake and decreases body weight in rhesus macaques. Diabetes 2005;54:3198-3204.
112. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999;402:656-660.
113. Kongnyuy EJ, Norman RJ, Flight IHK, Rees MC. Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution. The Cochrane Library 2009;2:1-72.
114. Kringelbach ML. Food for thought: hedonic experience beyond homeostasis in the human brain. Neuroscience 2004;126:807-819.
115. Kringelbach ML, Rolls ET. The functional neuroanatomy of the human orbitofrontal cortex: evidence from neuroimaging and neuropsychology. Prog Neurobiol 2004;72:341-372.
116. Kuiper GGJM, Shughrue PJ, Merchenthaler I, Gustafsson J+. The estrogen receptor [beta] subtype: a novel mediator of estrogen action in neuroendocrine systems. Front Neuroendocrinol 1998;19:253-286.
117. LaBar KS, Gitelman DR, Parrish TB, Kim YH, Nobre AC, Mesulam MM. Hunger selectively modulates corticolimbic activation to food stimuli in humans. Behav Neurosci 2001;115:493-500.
118. Laflamme N, Nappi RE, Drolet G, Labrie C, Rivest S. Expression and neuropeptidergic characterization of estrogen receptors (ERalpha and ERbeta) throughout the rat brain: anatomical evidence of distinct roles of each subtype. J Neurobiol 1998;36:357-378.
119. Le DSN, Pannacciulli N, Chen K, Del Parigi A, Salbe AD, Reiman EM, Krakoff J. Less activation of the left dorsolateral prefrontal cortex in response to a meal: a feature of obesity. Am J Clin Nutr 2006; 84:725-731.
120. Le Roux CW, Batterham RL, Aylwin SJB, Patterson M, Borg CM, Wynne KJ, Kent A, Vincent RP, Gardiner J, Ghatei MA et al.Attenuated peptide YY release in obese subjects is associated with reduced satiety. Endocrinology 2006;147:3-8.
121. Le Saux M, Morissette M, Di Paolo T. ER[beta] mediates the estradiol increase of D2 receptors in rat striatum and nucleus accumbens. Neuropharmacology 2006;50:451-457.
122. Lissner L, Stevens J, Levitsky DA, Rasmussen KM, Strupp BJ. Variation in energy intake during the menstrual cycle: implications for food-intake research. Am J Clin Nutr 1988;48:956-962.
123. Logothetis NK, Wandell BA. Interpreting the BOLD Signal. Annu Rev Physiol 2004;66:735-769.
124. Lou HC, Luber B, Crupain M, Keenan JP, Nowak M, Kjaer TW, Sackeim HA, Lisanby SH. Parietal cortex and representation of the mental self. Proc Natl Acad Sci USA 2004;101:6827-6832.
125. Lowe MR, van Steenburgh J, Ochner C, Coletta M. Neural correlates of individual differences related to appetite. Physiol Behav 2009; 91:432-439.
126. Ludwig M, Klein HH, Diedrich K, Ortmann O. Serum leptin concentrations throughout the menstrual cycle. Arch Gynecol Obstet 2000;263:99-101.
127. Lutz TA. Pancreatic amylin as a centrally acting satiating hormone. Curr Drug Targets 2005;6:181-189.
128. Lyons PM, Truswell AS, Mira M, Vizzard J, Abraham SF. Reduction of food intake in the ovulatory phase of the menstrual cycle. Am J Clin Nutr 1989; 49:1164-1168.
129. Malik S, McGlone F, Bedrossian D, Dagher A. Ghrelin modulates brain activity in areas that control appetitive behavior. Cell Metab 2008;7:400-409.
130. McFadden DW, Rudnicki M, Nussbaum MS, Balasubramaniam A, Fischer JE. Independent release of peptide YY (PYY) into the circulation and ileal lumen of the awake dog. J Surg Res 1989; 46:380-385.
131. Meguid MM, Glade MJ, Middleton FA. Weight regain after Roux-en-Y: A significant 20% complication related to PYY. Nutrition 2008; 24:832-842.
132. Mela DJ. Eating for pleasure or just wanting to eat? Reconsidering sensory hedonic responses as a driver of obesity. Appetite 2006;47:10-17.
133. Mercer JG, Hoggard N, Williams LM, Lawrence CB, Hannah LT, Morgan PJ, Trayhurn P. Coexpression of leptin receptor and preproneuropeptide y mrna in arcuate nucleus of mouse hypothalamus. J Neuroendocrinol 1996;8:733-735.
134. Miller JL, James GA, Goldstone AP, Couch JA, He G, Driscoll DJ, Liu Y. Enhanced activation of reward mediating prefrontal regions in response to food stimuli in Prader-Willi syndrome. J Neurol Neurosurg Psychiatry 2007;78:615-619.
135. Misra M, Miller KK, Tsai P, Gallagher K, Lin A, Lee N, Herzog DB, Klibanski A. Elevated peptide YY levels in adolescent girls with anorexia nervosa. J Clin Endocrinol Metab 2006;91:1027-1033.
136. Moran TH, Kinzig KP. Gastrointestinal satiety signals II. Cholecystokinin. Am J Physiol Gastrointest Liver Physiol 2004;286:G183-G188.
137. Moran TH, Katz LF, Plata-Salaman CR, Schwartz GJ. Disordered food intake and obesity in rats lacking cholecystokinin A receptors. Am J Physiol 1998;274:R618-R625.
138. Moran TH, Smedh U, Kinzig KP, Scott KA, Knipp S, Ladenheim EE. Peptide YY(3-36) inhibits gastric emptying and produces acute reductions in food intake in rhesus monkeys. Am J Physiol Regul Integr Comp Physiol 2005;288:R384-R388.
139. Morgane PJ, Galler JR, Mokler DJ. A review of systems and networks of the limbic forebrain/limbic midbrain. Prog Neurobiol 2005;75:143-160.
140. Murphy KG, Dhillo WS, Bloom SR. Gut peptides in the regulation of food intake and energy homeostasis. Endocr Rev 2006;27:719-727.
141. Must A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH. The disease burden associated with overweight and obesity. J Am Med Assoc 1999;282:1523-1529.
142. Nair DG. About being BOLD. Brain Res Rev 2005;50:229-243.
143. Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, Kangawa K, Matsukura S. A role for ghrelin in the central regulation of feeding. Nature 2001;409:194-198.
144. Neary NM, Small CJ, Druce MR, Park AJ, Ellis SM, Semjonous NM, Dakin CL, Filipsson K, Wang F, Kent AS et al. Peptide YY3-36 and Glucagon-like peptide-17-36 inhibit food intake additively. Endocrinology 2005;146:5120-5127.
145. Ogawa S, Lee TM, Nayak AS, Glynn P. Oxygenation-sensitive contrast in magnetic resonance image of rodent brain at high magnetic fields. Magn Reson Med 1990;14:68-78.
146. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of Overweight and Obesity in the United States, 1999-2004. JAMA 2006;295:1549-1555.
147. Olshansky SJ, Passaro DJ, Hershow RC, Layden J, Carnes BA, Brody J, Hayflick L, Butler RN, Allison DB, Ludwig DS. A potential decline in life expectancy in the united states in the 21st century. N Engl J Med 2005;352:1138-1145.
148. Ostlund Hann, Keller EVA, Hurd YL. Estrogen receptor gene expression in relation to neuropsychiatric disorders. Ann NY Acad Sci 2003; 1007:54-63.
149. Palmiter RD. Is dopamine a physiologically relevant mediator of feeding behavior? Trends Neurosci 2007;30:375-381.
150. Papadimitriou MA, Krzemien AA, Hahn PM, Van Vugt DA. Peptide YY3-36-induced inhibition of food intake in female monkeys. Brain Res 2007;1175:60-65.
151. Pelchat ML, Johnson A, Chan R, Valdez J, Ragland JD. Images of desire: food-craving activation during fMRI. NeuroImage 2004; 23:1486-1493.
152. Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T, Collins F. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 1995;269:540-543.
153. Petrovich GD, Gallagher M. Control of food consumption by learned cues: A forebrain-hypothalamic network. Physiol Behav 2007;91:397-403.
154. Petrovich GD, Setlow B, Holland PC, Gallagher M. Amygdalohypothalamic circuit allows learned cues to override satiety and promote eating. J Neurosci 2002;22:8748-8753.
155. Petrovich GD, Holland PC, Gallagher M. Amygdalar and prefrontal pathways to the lateral hypothalamus are activated by a learned cue that stimulates eating. J Neurosci 2005;25:8295-8302.
156. Pfluger PT, Kampe J, Castaneda TR, Vahl T, D'Alessio DA, Kruthaupt T, Benoit SC, Cuntz U, Rochlitz HJ, Moehlig M et al. Effect of human body weight changes on circulating levels of Peptide YY and Peptide YY3-36. J Clin Endocrinol Metab 2007;92:583-588.
157. Phan KL, Wager T, Taylor SF, Liberzon I. Functional neuroanatomy of emotion: a meta-analysis of emotion activation studies in PET and fMRI. NeuroImage 2002;16:331-348.
158. Porubska K, Veit R, Preissl H, Fritsche A, Birbaumer N. Subjective feeling of appetite modulates brain activity: An fMRI study. NeuroImage 2006; 32:1273-1280.
159. Pullman J, Darsow T, Frias JP. Pramlintide in the management of insulin-using patients with type 2 and type 1 diabetes. Vasc Health Risk Manag 2006;2:203-212.
160. Rayner M, Scarborough P. The burden of food related ill health in the UK. J Epidemiol Community Health 2005;59:1054-1057.
161. Redgrave GW, Bakker A, Bello NT, Caffo BS, Coughlin JW, Guarda AS, McEntee JE, Pekar JJ, Reinblatt SP, Verduzco G et al. Differential brain activation in anorexia nervosa to Fat and Thin words during a Stroop task [Miscellaneous Article]. Neuroreport 2008;19:1181-1185.
162. Reed SC, Levin FR, Evans SM. Changes in mood, cognitive performance and appetite in the late luteal and follicular phases of the menstrual cycle in women with and without PMDD (premenstrual dysphoric disorder). Horm Behav 2008;54:185-193.
163. Reimer RA, Debert CT, House JL, Poulin MJ. Dietary and metabolic differences in pre-versus postmenopausal women taking or not taking hormone replacement therapy. Physiol Behav 2005;84:303-312.
164. Reubinoff BE, Wurtman J, Rojansky N, Adler D, Stein P, Schenker JG, Brzezinski A. Effects of hormone replacement therapy on weight, body composition, fat distribution, and food intake in early postmenopausal women: a prospective study. Fertil Steril 1995; 64:963-968.
165. Riad-Gabriel MG, Jinagouda SD, Sharma A, Boyadjian R, Saad MF. Changes in plasma leptin during the menstrual cycle. Eur J Endocrinol 1998; 139:528-531.
166. Rolls ET. The functions of the orbitofrontal cortex. Brain Cogn 2004; 55:11-29.
167. Rolls ET, McCabe C. Enhanced affective brain representations of chocolate in cravers vs. non-cravers. Eur J Neurosci 2007;26:1067-1076.
168. Rosenbaum M, Sy M, Pavlovich K, Leibel RL, Hirsch J. Leptin reverses weight loss-induced changes in regional neural activity responses to visual food stimuli. J Clin Invest 2008;118:2583-2591.
169. Rosenblatt H, Dyrenfurth I, Ferin M, vande Wiele RL. Food intake and the menstrual cycle in rhesus monkeys. Physiol Behav 1980;24:447-449.
170. Rosenbloom AL, Joe JR, Young RS, Winter WE. Emerging epidemic of type 2 diabetes in youth. Diabetes Care 1999;22:345-354.
171. Roth JD, Hughes H, Kendall E, Baron AD, Anderson CM. Antiobesity effects of the {beta}-cell hormone amylin in diet-induced obese rats: effects on food intake, body weight, composition, energy expenditure, and gene expression. Endocrinology 2006;147:5855-5864.
172. Rothemund Y, Preuschhof C, Bohner G, Bauknecht HC, Klingebiel R, Flor H, Klapp BF. Differential activation of the dorsal striatum by high-calorie visual food stimuli in obese individuals. NeuroImage 2007; 37:410-421.
173. Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, Williams SC, Richardson JA, Kozlowski GP, Wilson S et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and g protein-coupled receptors that regulate feeding behavior. Cell 1998; 92:573-585.
174. Santel S, Baving L, Krauel K, Munte TF, Rotte M. Hunger and satiety in anorexia nervosa: fMRI during cognitive processing of food pictures. Brain Res 2006;1114:138-148.
175. Saper CB, Chou TC, Elmquist JK. The need to feed: homeostatic and hedonic control of eating. Neuron 2002;36:199-211.
176. Scarpace PJ, Tumer N. Peripheral and hypothalamic leptin resistance with age-related obesity. Physiol Behav 2001;74:721-727.
177. Scheid JL, Williams NI, West SL, VanHeest JL, Souza MJD. Elevated PYY is associated with energy deficiency and indices of subclinical disordered eating in exercising women with hypothalamic amenorrhea. Appetite 2009;52:184-192.
178. Schienle A, Schafer A, Hermann A, Vaitl D. Binge-eating disorder: reward sensitivity and brain activation to images of food. Biol Psychiatry 2009; 65:654-661.
179. Schneider F, Habel U, Wagner M, Franke P, Salloum JB, Shah NJ, Toni I, Sulzbach C, Honig K, Maier W et al. Subcortical correlates of craving in recently abstinent alcoholic patients. Am J Psychiatry 2001; 158:1075-1083.
180. Schoenbaum G, Chiba AA, Gallagher M. Orbitofrontal cortex and basolateral amygdala encode expected outcome during learning. Nat Neurosci 1998;1:155-159.
181. Schwartz MW, Seeley RJ, Campfield LA, Burn P, Baskin DG. Identification of targets of leptin action in rat hypothalamus. J Clin Invest 1996; 98:1101-1106.
182. Schwartz MW, Seeley RJ, Woods SC, Weigle DS, Campfield LA, Burn P, Baskin DG. Leptin increases hypothalamic pro-opiomelanocortin mrna expression in the rostral arcuate nucleus. Diabetes 1997;46:2119-2123.
183. Shimizu H, Shimomura Y, Nakanishi Y, Futawatari T, Ohtani K, Sato N, Mori M. Estrogen increases in vivo leptin production in rats and human subjects. J Endocrinol 1997;154:285-292.
184. Shughrue PJ, Lane MV, Merchenthaler I. Comparative distribution of estrogen receptor-alpha and -beta mRNA in the rat central nervous system. J Comp Neurol 1997;388:507-525.
185. Siegel JM. Narcolepsy: a key role for hypocretins (Orexins). Cell 1999; 98:409-412.
186. Silverman JL, Koenig JI. Evidence for the involvement of ER[beta] and RGS9-2 in 17-[beta] estradiol enhancement of amphetamine-induced place preference behavior. Horm Behav 2007;52:146-155.
187. Sloth B, Davidsen L, Holst JJ, Flint A, Astrup A. Effect of subcutaneous injections of PYY1-36 and PYY3-36 on appetite, ad libitum energy intake, and plasma free fatty acid concentration in obese males. Am J Physiol Endocrinol Metab 2007a;293:E604-E609.
188. Sloth B, Holst JJ, Flint A, Gregersen NT, Astrup A. Effects of PYY1-36 and PYY3-36 on appetite, energy intake, energy expenditure, glucose and fat metabolism in obese and lean subjects. Am J Physiol Endocrinol Metab 2007b;292:E1062-E1068.
189. Smith SR, Aronne LJ, Burns CM, Kesty NC, Halseth AE,Weyer C. Sustained weight loss following 12-month pramlintide treatment as an adjunct to lifestyle intervention in obesity. Diabetes Care 2008;31:1816-1823.
190. St-Onge MP, Sy M, Heymsfield SB, Hirsch J. Human cortical specialization for food: a functional magnetic resonance imaging investigation. J Nutr 2005;135:1014-1018.
191. Stoeckel LE, Cox JE, Cook EW III, Weller RE. Motivational state modulates the hedonic value of food images differently in men and women. Appetite 2007;48:139-144.
192. Stoeckel LE, Weller RE, Cook EW III, Twieg DB, Knowlton RC, Cox JE. Widespread reward-system activation in obese women in response to pictures of high-calorie foods. NeuroImage 2008;41:636-647.
193. Tarttelin MF, Gorski RA. The effects of ovarian steroids on food and water intake and body weight in the female rat. Acta Endocrinol 1973; 72:551-568.
194. Tataranni PA, Gautier JF, Chen K, Uecker A, Bandy D, Salbe AD, Pratley RE, Lawson M, Reiman EM, Ravussin E. Neuroanatomical correlates of hunger and satiation in humans using positron emission tomography. Proc Natl Acad Sci USA 1999;96:4569-4574.
195. Teirmaa T, Luukkaa V, Rouru J, Koulu M, Huupponen R. Correlation between circulating leptin and luteinizing hormone during the menstrual cycle in normal-weight women. Eur J Endocrinol 1998; 139:190-194.
196. The Practice Committee of the American Society for Reproductive Medicine. Obesity and reproduction: an educational bulletin. Fertil Steril 2008;90:S21-S29.
197. Trinko R, Sears RM, Guarnieri DJ, DiLeone RJ. Neural mechanisms underlying obesity and drug addiction. Physiol Behav 2007;91:499-505.
198. Tritos NA, Segal-Lieberman G, Vezeridis PS, Maratos-Flier E. Estradiol-induced anorexia is independent of leptin and melanin-concentrating hormone. Obesity Res 2004;12:716-724.
199. Uher R, Brammer MJ, Murphy T, Campbell IC, Ng VW, Williams SCR, Treasure J. Recovery and chronicity in anorexia nervosa: brain activity associated with differential outcomes. Biol Psychiatry 2003; 54:934-942.
200. Uher R, Murphy T, Brammer MJ, Dalgleish T, Phillips ML, Ng VW, Andrew CM, Williams SCR, Campbell IC, Treasure J. Medial prefrontal cortex activity associated with symptom provocation in eating disorders. Am J Psychiatry 2004;161:1238-1246.
201. Uher R, Treasure J, Heining M, Brammer MJ, Campbell IC. Cerebral processing of food-related stimuli: Effects of fasting and gender. Behav Brain Res 2006;169:111-119.
202. Volkow ND, Wise RA. How can drug addiction help us understand obesity? Nat Neurosci 2005;8:555-560.
203. Volkow ND, Wang GJ, Fowler JS, Telang F. Overlapping neuronal circuits in addiction and obesity: evidence of systems pathology. Philos Trans R Soc B: Biol Sci 2008;363:3191-3200.
204. Wade GN. Some effects of ovarian hormones on food intake and body weight in female rats. J Comp Physiol Psychol 1975;88:183-193.
205. Wade GN, Gray JM. Gonadal effects on food intake and adiposity: A metabolic hypothesis. Physiol Behav 1979;22:583-593.
206. Wade GN, Gray JM, Bartness TJ. Gonadal influences on adiposity. International Journal of Obesity 1985;9(Suppl. 1):83-92.
207. Wang GJ, Volkow ND, Logan J, Pappas NR,Wong CT, ZhuW, Netusll N, Fowler JS. Brain dopamine and obesity. Lancet 2001;357:354-357.
208. Wang G, Lee HM, Englander E, Greeley GH. Ghrelin-not just another stomach hormone. Regul Pept 2002a;105:75-81.
209. Wang JX, Davies MJ, Norman RJ. Obesity increases the risk of spontaneous abortion during infertility treatment. Obes Res 2002b;10:551-554.
210. Wang GJ, Volkow ND, Telang F, Jayne M, Ma J, Rao M, ZhuW,Wong CT, Pappas NR, Geliebter A et al. Exposure to appetitive food stimuli markedly activates the human brain. NeuroImage 2004;21:1790-1797.
211. Watkins ML, Rasmussen SA, Honein MA, Botto LD, Moore CA. Maternal obesity and risk for birth defects. Pediatrics 2003;111:1152-1158.
212. Weiss JL, Malone FD, Emig D, Ball RH, Nyberg DA, Comstock CH, Saade G, Eddleman K, Carter SM, Craigo SD et al. Obesity, obstetric complications and Cesarean delivery rate-a population-based screening study. Am J Obstet Gynecol 2004;190:1091-1097.
213. Welt CK, Chan JL, Bullen J, Murphy R, Smith P, Depaoli AM, Karalis A, Mantzoros CS. Recombinant human leptin in women with hypothalamic amenorrhea. N Engl J Med 2004;351:987-997.
214. West DB, Fey D, Woods SC. Cholecystokinin persistently suppresses meal size but not food intake in free-feeding rats. Am J Physiol Regul Integr Comp Physiol 1984;246:R776-R787.
215. Williamson DA, Ravussin E, Wong ML, Wagner A, DiPaoli A, Caglayan S, Ozata M, Martin C, Walden H, Arnett C et al. Microanalysis of eating behavior of three leptin deficient adults treated with leptin therapy. Appetite 2005;45:75-80.
216. Wren AM, Seal LJ, Cohen MA, Brynes AE, Frost GS, Murphy KG, Dhillo WS, Ghatei MA, Bloom SR. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 2001;86:5992.
217. Wunder DM, Yared M, Bersinger NA, Widmer D, Kretschmer R, Birkhauser MH. Serum leptin and C-reactive protein levels in the physiological spontaneous menstrual cycle in reproductive age women. Eur J Endocrinol 2006;155:137-142.
218. Wynne K, Park AJ, Small CJ, Meeran K, Ghatei MA, Frost GS, Bloom SR. Oxyntomodulin increases energy expenditure in addition to decreasing energy intake in overweight and obese humans: a randomised controlled trial. Int J Obes 2006;30:1729-1736.
219. Zelissen PM, Stenlof K, Lean ME, Fogteloo J, Keulen ET, Wilding J, Finer N, Rossner S, Lawrence E, Fletcher C et al. Effect of three treatment schedules of recombinant methionyl human leptin on body weight in obese adults: a randomized, placebo-controlled trial. Diabetes Obes Metab 2005;7:755-761.
220. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994;372:425-432.
221. Zheng H, Corkern M, Stoyanova I, Patterson LM, Tian R, Berthoud HR. Peptides that regulate food intake: appetite-inducing accumbens manipulation activates hypothalamic orexin neurons and inhibits POMC neurons. Am J Physiol Regul Integr Comp Physiol 2003;284:R1436-R1444.
222. Zigman JM, Jones JE, Lee CE, Saper CB, Elmquist JK. Expression of ghrelin receptor mRNA in the rat and the mouse brain. J Comp Neurol 2006; 494:528-548.